IAEA and RaySearch partner to expand radiotherapy access to radiotherapy through the Rays of Hope initiative
RaySearch Laboratories AB (publ) and the International Atomic Energy Agency (IAEA) are proud to announce the signing of an agreement at the 70th IAEA General Conference, bringing RaySearch into the Rays of Hope initiative.
The multi-year partnership aims to strengthen cooperation and expand access to safe, effective and sustainable radiotherapy services, particularly in countries and regions where access to radiotherapy remains limited.
The agreement establishes a framework for collaboration in areas including awareness-raising and research in radiotherapy treatment planning and quality assurance. It also includes the potential provision of software solutions to support selected cancer centers participating in Rays of Hope, including Anchor Centers that serve as regional knowledge and capacity-building hubs.
“Partnerships with industry are helping the IAEA expand access to cancer diagnosis and treatment around the world. Working together, we can bring life-saving cancer services to more people, no matter where they live," says IAEA Director General Rafael Mariano Grossi.
While investments in radiotherapy equipment are critical, advanced software plays an equally important role in ensuring that treatments are delivered safely, accurately and efficiently. Treatment planning systems and oncology information systems enable radiation oncologists and medical physicists to design personalized treatment plans, streamline clinical workflows and support quality assurance, helping healthcare providers make the most of available resources.
Through the collaboration, RaySearch may explore opportunities to support facilities identified by the IAEA with software, application-specific training, and technical expertise. With its vendor-agnostic approach and broad range of cancer care solutions, RaySearch can help strengthen radiotherapy capacity and support high-quality cancer care.
"Cancer is a global challenge, but access to advanced radiotherapy is still far from equal. In many parts of the world, access to radiotherapy remains limited. We are proud to collaborate with the IAEA and contribute our software, expertise and experience to the Rays of Hope initiative. Together, we hope to strengthen radiotherapy capabilities and support healthcare professionals in delivering safe and effective treatments to more patients around the world," says Johan Löf, founder and CEO of RaySearch Laboratories.
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB
Tel: +46 (0) 8 510 530 00
Carolina Strömlid, Head of Investor Relations, RaySearch Laboratories AB
Tel: +46 (0) 708 807 173
ir@raysearchlabs.com
About Rays of Hope
Rays of Hope is an IAEA initiative aimed at expanding access to cancer care, particularly in low- and middle-income countries where radiotherapy services are limited or unavailable. The initiative supports countries in building and strengthening safe and effective radiotherapy capabilities through training, guidance, quality assurance and equipment. One of the pillars of Rays of Hope is the establishment of Anchor Centres, regional knowledge and capacity building hubs, which ensure the long-term impact and sustainability of Rays of Hope. Through the Anchor Centre network and partnerships with governments, international organizations and the private sector, Rays of Hope promotes sustainable, high-impact solutions tailored to national needs and priorities. It aims to help close the global gap in access to cancer care.
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure, and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems. RaySearch’s software has been sold to over 1,200 clinics in 54 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003 (STO: RAY B). More information is available at raysearchlabs.com.
Learn more about us on:
LinkedIn
YouTube
*RaySearch products are subject to regulatory clearance in some markets.